S-citalopram imprinted monolithic columns for capillary electrochromatography enantioseparations.
Derazshamshir A, Göktürk I, Yılmaz F, Denizli A.
Electrophoresis · research support, non-u.s. gov't; journal article · DOI 10.1002/elps.202100222 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för escitalopram. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
19 träffarCitalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.
Ji Y, Schaid DJ, Desta Z, Kubo M, Batzler AJ, Snyder K, Mushiroda T, Kamatani N, Ogburn E, Hall-Flavin D, Flockhart D, Nakamura Y, Mrazek DA, Weinshilboum RM.
Br J Clin Pharmacol · clinical trial; research-article; journal article; research support, n.i.h., extramural · DOI 10.1111/bcp.12348A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
Sanchez C, Reines EH, Montgomery SA.
Int Clin Psychopharmacol · comparative study; review-article; review; journal article · DOI 10.1097/yic.0000000000000023Debunking the placebo effect in depression: the effect of patient and investigator expectation on escitalopram efficacy.
Nehama Y, Rabinowitz I, Baruch Y, Mandel A, Lurie I, Barak Y.
Int Clin Psychopharmacol · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1097/yic.0000000000000013Escitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome: a randomized, double-blind, placebo-controlled study.
Hoare J, Carey P, Joska JA, Carrara H, Sorsdahl K, Stein DJ.
J Nerv Ment Dis · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1097/nmd.0000000000000082Clinical pharmacology review of escitalopram for the treatment of depression.
Pastoor D, Gobburu J.
Expert Opin Drug Metab Toxicol · review; journal article · DOI 10.1517/17425255.2014.863873Escitalopram-induced Parkinsonism.
Ak S, Anıl Yağcıoğlu AE.
Gen Hosp Psychiatry · journal article; case reports · DOI 10.1016/j.genhosppsych.2013.09.010Effects of diverse psychopharmacological substances on the activity of brain prolyl oligopeptidase.
Peltonen I, Männistö PT.
Basic Clin Pharmacol Toxicol · research support, non-u.s. gov't; journal article · DOI 10.1111/j.1742-7843.2010.00626.xEscitalopram is a weak inhibitor of the CYP2D6-catalyzed O-demethylation of (+)-tramadol but does not reduce the hypoalgesic effect in experimental pain.
Noehr-Jensen L, Zwisler ST, Larsen F, Sindrup SH, Damkier P, Brosen K.
Clin Pharmacol Ther · clinical trial, phase iii; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1038/clpt.2009.154[Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
Mnie-Filali O, El Mansari M, Scarna H, Zimmer L, Sánchez C, Haddjeri N.
Encephale · review; journal article; english abstract · DOI 10.1016/j.encep.2007.11.001Escitalopram in the treatment of anxiety symptoms associated with depression.
Bandelow B, Andersen HF, Dolberg OT.
Depress Anxiety · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1002/da.20141Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis.
Kasper S, Spadone C, Verpillat P, Angst J.
Int Clin Psychopharmacol · research support, non-u.s. gov't; journal article · DOI 10.1097/01.yic.0000194375.42589.c3Escitalopram: a review of its use in the management of anxiety disorders.
Dhillon S, Scott LJ, Plosker GL.
CNS Drugs · review; evaluation study; journal article · DOI 10.2165/00023210-200620090-00010Escitalopram: a review of its use in the management of major depressive disorder.
Murdoch D, Keam SJ.
Drugs · review; journal article · DOI 10.2165/00003495-200565160-00013Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria.
Hemels ME, Kasper S, Walter E, Einarson TR.
Curr Med Res Opin · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1185/030079904125003737Therapeutic drug monitoring of 13 antidepressant and five neuroleptic drugs in serum with liquid chromatography-electrospray ionization mass spectrometry.
Gutteck U, Rentsch KM.
Clin Chem Lab Med · journal article · DOI 10.1515/cclm.2003.240R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model.
Sánchez C, Gruca P, Papp M.
Behav Pharmacol · journal article · DOI 10.1097/01.fbp.0000087733.21047.60Escitalopram: a pharmacoeconomic review of its use in depression.
Croom KF, Plosker GL.
Pharmacoeconomics · comparative study; review; journal article · DOI 10.2165/00019053-200321160-00004A pharmacoeconomic evaluation of escitalopram, a new selective serotonin reuptake inhibitor. Comparison of cost-effectiveness between escitalopram, citalopram, fluoxetine, and venlafaxine for the treatment of depression in Norway.
François C, Toumi M, Aakhus AM, Hansen K.
Eur J Health Econ · journal article · DOI 10.1007/s10198-002-0139-0